Neuronetics

-$0.01 (-0.28%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments.

CEO

Keith J. Sullivan

Employees

126

Headquarters

Malvern, Pennsylvania

Founded

2001

STIM Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

283.00K

High today

$3.58

Low today

$3.34

Open price

$3.50

Volume

330.32K

52 Week high

$22.38

52 Week low

$3.34

STIM News

Simply Wall StJan 19

Is Neuronetics Weighed On By Its Debt Load?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky

STIM Earnings

-$0.51

-$0.34

-$0.17

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Mar 1, Pre-Market

Why Robinhood?

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. View more

Is Neuronetics Weighed On By Its Debt Load?

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments.